0000000000803440

AUTHOR

Mark Cropley

0000-0002-8483-1797

showing 2 related works from this author

Reduction of depressive symptoms during inpatient treatment is not associated with changes in heart rate variability

2021

Vagally mediated heart rate variability (HRV) is a psychophysiological indicator of mental and physical health. Limited research suggests there is reduced vagal activity and resulting lower HRV in patients with Major Depressive Disorder (MDD); however little is actually known about the association between HRV and symptoms of depression and whether the association mirrors symptom improvement following psychotherapy. The aim of this study was to investigate the association between antidepressant therapy, symptom change and HRV in 50 inpatients (68% females; 17–68 years) with a diagnosis of MDD. Severity of depressive symptoms was assessed by self-report (Beck Depression Inventory II) and the …

MalePsychometricsSocial SciencesCardiovascular MedicineMedical ConditionsHeart RateMedicine and Health SciencesPsychologyMedicineHeart rate variabilityDepression (differential diagnoses)MultidisciplinaryDepressionPharmaceuticsQRDrugsAntidepressantsMiddle AgedAntidepressant Drug TherapyCardiovascular DiseasesMedicineMajor depressive disorderFemaleResearch Articlecirculatory and respiratory physiologyClinical psychologyNeurological Drug TherapyAdultPatientsPsychometricsAdolescentScienceCardiologyYoung AdultDrug Therapy:Medisinske Fag: 700 [VDP]Rating scaleMental Health and PsychiatryHumansIn patientDepressive symptomsAgedPharmacologyInpatientsDepressive Disorder MajorMood Disordersbusiness.industryBeck Depression InventoryBiology and Life Sciencesmedicine.diseaseHealth CarePsychotherapybusinessMental Health Therapies
researchProduct

The cortisol awakening response at admission to hospital predicts depression severity after discharge in MDD patients.

2019

Major Depressive Disorder (MDD) is associated with hypothalamic-pituitary-adrenal axis (HPA) dysregulation and altered cortisol awakening response (CAR), a non-invasive biomarker for HPA axis reactivity. We theorized that the CAR resembles the accumulated effects of depression over time, and may therefore predict depressive symptom severity once patients return home following inpatient treatment. Two studies are reported. In Study 1 (n = 101; 57% female), the CAR was measured at intake and self-ratings of depression severity was assessed six weeks following discharge. Study 2 (n = 127; 58% female) was a replication and extension of Study 1 where a follow-up assessment of self-rated depressi…

AdultMalemedicine.medical_specialtyHypothalamo-Hypophyseal SystemCortisol awakening responseAdolescentHydrocortisoneNegative associationSeverity of Illness Index03 medical and health sciencesYoung Adult0302 clinical medicinePatient AdmissionInternal medicinemedicineHumansSalivaBiological PsychiatryDepression (differential diagnoses)AgedDepressive Disorder Majorbusiness.industryAfter dischargeMiddle Agedmedicine.diseasePrognosisPatient Discharge030227 psychiatryPsychiatry and Mental healthMoodMajor depressive disorderBiomarker (medicine)FemalePost treatmentbusiness030217 neurology & neurosurgeryBiomarkersFollow-Up StudiesJournal of psychiatric research
researchProduct